ID
46163
Description
Principal Investigator: ES Orwoll, MD, Oregon Health and Sciences University, OR, USA MeSH: Osteoporosis,Osteoarthritis,Sleep https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000373 The Osteoporotic Fractures in Men Study (MrOS) is a multi-center prospective, longitudinal, observational study of risk factors for vertebral and all non-vertebral fractures in older men, and of the sequelae of fractures in men. The original specific aims of the study include: (1) to define the skeletal determinants of fracture risk in older men, (2) to define lifestyle and medical factors related to fracture risk, (3) to establish the contribution of fall frequency to fracture risk in older men, (4) to determine to what extent androgen and estrogen concentrations influence fracture risk, (5) to examine the effects of fractures on quality of life, (6) to identify sex differences in the predictors and outcomes of fracture, (7) to collect and store serum, urine and DNA for future analyses as directed by emerging evidence in the fields of aging and skeletal health, and (8) define the extent to which bone mass/fracture risk and prostate diseases are linked. The MrOS study population consists of 5,994 community dwelling, ambulatory men aged 65 years or older from six communities in the United States (Birmingham, AL; Minneapolis, MN; Palo Alto, CA; Monongahela Valley near Pittsburgh, PA; Portland, OR; and San Diego, CA). Inclusion criteria were designed to provide a study cohort that is representative of the broad population of older men. The inclusion criteria were: (1) ability to walk without the assistance of another, (2) absence of bilateral hip replacements, (3) ability to provide self-reported data, (4) residence near a clinical site for the duration of the study, (5) absence of a medical condition that (in the judgment of the investigator) would result in imminent death, and (6) ability to understand and sign an informed consent. To qualify as an enrollee, the participant had to provide written informed consent, complete the self-administered questionnaire (SAQ), attend the clinic visit, and complete at least the anthropometric, DEXA, and vertebral X-ray procedures. There were no other exclusion criteria. The baseline examination was completed over a 25-month period from March 2000 to April 2002. Participants completed questionnaires regarding medical history, medications, physical activity, diet, alcohol intake, and cigarette smoking. Objective measures of anthropometric, neuromuscular, vision, strength, and cognitive variables were obtained at a clinic visit. Skeletal assessments included DEXA, calcaneal ultrasound, and vertebral radiographs. Vertebral and proximal femoral QCT was performed on a subset (65%) of participants. Serum, urine, and whole blood specimens were collected. During the study period, participants complete a tri-annual questionnaire every four months that obtains information concerning the occurrence of incident falls and fractures. Follow-up is over 99% complete. All reported fractures are confirmed using physician review of radiology reports or study radiologist review of x-rays. All deaths are also centrally adjudicated using death certificates and recent hospitalization records. In additional to the baseline study visit and tri-annual questionnaires, all surviving active participants were invited to follow-up visits and questionnaires. A second comprehensive clinic visit was completed between March 2005 and May 2006 or about 4.5 years after baseline. Most baseline measures, including vertebral radiographs, were repeated at the second visit. A third comprehensive clinic visit was completed between March 2007 and March 2009 or about 7.0 years after baseline. Many baseline measures were repeated at the third visit. A measure of energy expenditure was also obtained utilizing an accelerometer based armband device. Surviving participants have also completed two extensive mailed questionnaires designed to updated information obtained at clinic visits. The first questionnaire was mailed between baseline and visit 2 between July 2002 and March 2004. The second questionnaire was mailed after the third questionnaire between March 2009 and February 2011. The MrOS Sleep Study, an ancillary study of the parent MrOS cohort, was conducted between December 2003 and March 2005 and recruited 3,135 MrOS participants for a comprehensive sleep assessment. Men were screened for nightly use of mechanical devices during sleep including pressure mask for sleep apnea (CPAP or BiPAP), mouthpiece for snoring or sleep apnea, or oxygen therapy and were generally excluded. The sleep visit included objective measures of sleep using actigraphy and polysomnography. Other measures at the sleep visit include neuropsychiatric measures, performance measures, health related questionnaires, routine exam measures previously completed at MrOS clinic visits and a urine and serum specimen collection. During the sleep study period, participants complete a tri-annual questionnaire every four months that contains information about incident cardiovascular events. All reported events are centrally adjudicated utilizing hospital records, study ECGs and other supporting documentation. The Hip Osteoarthritis study, another ancillary study of the parent MrOS cohort, was completed at the second clinic visit between March 2005 and May 2006. Participants were asked for consent for a hip x-ray and osteoarthritis measurements were obtained from these x-rays. DNA was extracted from baseline whole blood samples for use in genetic research. Consent for use of DNA was obtained through written consent. Raw GWAS data is housed at the study's coordinating center and not released as part of the dbGAP release. The raw data can be requested from the study's coordinating center. Only QC cleaned Plink files are available on dbGAP.
Link
Keywords
Versions (3)
- 9/26/22 9/26/22 - Chiara Middel
- 10/12/22 10/12/22 - Adrian Schulz
- 1/29/25 1/29/25 - Akane Nishihara
Copyright Holder
ES Orwoll, MD, Oregon Health and Sciences University, OR, USA
Uploaded on
January 29, 2025
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs000373 Osteoporotic Fractures in Men (MrOS)
Eligibility Criteria
- StudyEvent: dbGaP phs000373 Osteoporotic Fractures in Men (MrOS)
- Eligibility Criteria
- Subject ID, subject source, source subject ID, and consent group of participants involved in the "Osteoporotic Fractures in Men (MrOS)" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable obtained from participants involved in the "Osteoporotic Fractures in Men (MrOS)" project.
- Subject ID, clinic site, gender, age, race, cohort, acuity, bone of femur, Bone Mineral Density (BMD), Body Mass Index (BMI), Broadband Ultrasound Attenuation (BUA), calcium, circadian rhythm, cross-sectional area, chair stand with use of arms, contrast sensitivity, depth perception levels, Digit Symbol, femoral neck, grip strength, height, hip - grading disease, incident of fracture, Instrumental Activities of Daily Living (IADL), kidney stones, leg power, Modified Mini-Mental State Examination (3MS), mobility limitations, MrOS trails, Overall Arousal Index, Pim, pseudo F value, QUI mean, Respiratory Disturbance Index (RDI), sleeping, SOS mean, vital status, Vertebral Strength Index, weight, walking, smoking, and alcohol consumption of participants involved in the "Osteoporotic Fractures in Men (MrOS)" project.
- Sample ID, body site where sample was obtained, tumor status of sample, analyte type, and histological type of sample obtained from participants involved in the "Osteoporotic Fractures in Men (MrOS)" project.
Similar models
Eligibility Criteria
- StudyEvent: dbGaP phs000373 Osteoporotic Fractures in Men (MrOS)
- Eligibility Criteria
- Subject ID, subject source, source subject ID, and consent group of participants involved in the "Osteoporotic Fractures in Men (MrOS)" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable obtained from participants involved in the "Osteoporotic Fractures in Men (MrOS)" project.
- Subject ID, clinic site, gender, age, race, cohort, acuity, bone of femur, Bone Mineral Density (BMD), Body Mass Index (BMI), Broadband Ultrasound Attenuation (BUA), calcium, circadian rhythm, cross-sectional area, chair stand with use of arms, contrast sensitivity, depth perception levels, Digit Symbol, femoral neck, grip strength, height, hip - grading disease, incident of fracture, Instrumental Activities of Daily Living (IADL), kidney stones, leg power, Modified Mini-Mental State Examination (3MS), mobility limitations, MrOS trails, Overall Arousal Index, Pim, pseudo F value, QUI mean, Respiratory Disturbance Index (RDI), sleeping, SOS mean, vital status, Vertebral Strength Index, weight, walking, smoking, and alcohol consumption of participants involved in the "Osteoporotic Fractures in Men (MrOS)" project.
- Sample ID, body site where sample was obtained, tumor status of sample, analyte type, and histological type of sample obtained from participants involved in the "Osteoporotic Fractures in Men (MrOS)" project.
C0001779 (UMLS CUI [1,2])
C4722228 (UMLS CUI [1,3])
C1298908 (UMLS CUI [1,4])
C2732563 (UMLS CUI [1,5])
C0681906 (UMLS CUI [1,6])
C1830482 (UMLS CUI [1,7])
C2347790 (UMLS CUI [1,8])
C1298908 (UMLS CUI [1,9])
C4745084 (UMLS CUI [1,10])
C0332294 (UMLS CUI [1,11])
C2363727 (UMLS CUI [1,12])
C4304770 (UMLS CUI [1,13])
C0205197 (UMLS CUI [1,2])
C0034394 (UMLS CUI [1,3])
C0008952 (UMLS CUI [1,4])
C1999232 (UMLS CUI [1,5])
C0205197 (UMLS CUI [1,6])
C0815129 (UMLS CUI [1,7])
C4537707 (UMLS CUI [1,8])
C0203139 (UMLS CUI [1,9])
No comments